샘플 요청 목록

 카트 문의
시장보고서
상품코드
1857375

세계의 성인 혈색소병증 검사 시장

Adult Hemoglobinopathy Testing
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 174 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 성인 혈색소병증 검사 시장은 2030년까지 5억 1,450만 달러에 이를 전망

2024년에 3억 9,960만 달러로 추정되는 성인 혈색소병증 검사 세계 시장은 2024-2030년간 CAGR 4.3%로 성장하여 2030년에는 5억 1,450만 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 참조 실험실은 CAGR 4.4%를 나타내고, 분석 기간 종료시에는 3억 3,720만 달러에 이를 것으로 예측됩니다. 병원의 성장률은 분석 기간중 CAGR 4.4%로 추정됩니다.

미국 시장은 1억 500만 달러로 추정, 중국은 CAGR6.6%로 성장 예측

미국의 성인 혈색소병증 검사 시장은 2024년에 1억 500만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 1억 1,020만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.6%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 2.7%와 3.6%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 3.0%를 보일 것으로 예측됩니다.

세계의 성인 혈색소병증 검사 시장 동향과 촉진요인

성인 헤모글로빈혈증 검사란 무엇이며, 왜 중요한가?

성인 헤모글로빈혈증 검사는 성인의 겸상 적혈구증, 지중해 빈혈과 같은 헤모글로빈 장애를 감지하는 데 사용되는 중요한 진단 과정입니다. 이러한 유전적 질환은 빈혈, 통증, 장기 장애 등 심각한 건강 합병증을 유발할 수 있습니다. 검사에는 일반적으로 전혈구 계산(CBC), 헤모글로빈 전기영동, 고속 액체 크로마토그래피(HPLC), 비정상적인 헤모글로빈 변이체 및 돌연변이를 식별하는 유전자 검사 등의 방법을 결합합니다. 헤모글로빈 이상증 검사를 통한 조기 및 정확한 진단은 효과적인 질환 관리에 매우 중요하며, 이를 통해 의료진은 환자의 예후와 삶의 질을 크게 향상시킬 수 있는 맞춤형 치료 계획을 수립할 수 있습니다. 이러한 질환은 유전되는 경우가 많기 때문에 검사는 유전 상담과 가족계획에도 중요한 역할을 하고 있습니다.

기술 혁신은 어떻게 헤모글로빈혈증 검사를 강화하는가?

기술의 발전은 헤모글로빈혈증 검사의 능력과 정확도를 크게 향상시켰습니다. 차세대 염기서열 분석(NGS)과 첨단 유전자 검사법의 통합은 이 분야에 혁명을 가져왔으며, 헤모글로빈 장애와 관련된 유전자 변이를 보다 정확하게 식별할 수 있게 되었습니다. 생물정보학 및 데이터 분석의 혁신은 복잡한 유전자 데이터의 해석을 더욱 강화하여 희귀하고 미묘한 돌연변이도 감지할 수 있게 해줍니다. 또한, 액체생검, Point of Care 검사 등 비침습적 검사 기술의 발달로 환자들의 접근성과 편의성이 향상되고 있습니다. 이러한 발전은 진단 정확도를 높일 뿐만 아니라 기존 검사법과 관련된 시간과 비용을 절감하고, 헤모글로빈 이상증 검사를 보다 효율적이고 광범위하게 이용할 수 있게 합니다.

헤모글로빈혈증 검사의 보급을 촉진하는 추세는?

몇 가지 중요한 동향이 헬스케어 분야에서 성인 헤모글로빈혈증 검사의 채택을 촉진하고 있습니다. 전 세계적으로 헤모글로빈 이상증의 유병률 증가는 중요한 요인이며, 조기 발견 및 관리는 장기적인 건강 영향을 줄이기 위해 필수적입니다. 유전성 질환에 대한 인식과 교육 캠페인이 증가하면서 더 많은 사람들이 검사를 받도록 독려하고 있습니다. 유전성 질환에 대한 귀중한 통찰력을 제공하고 가족계획 결정의 지침이 되는 유전 상담 서비스의 확대는 진단 검사에 대한 수요를 더욱 증가시키고 있습니다. 또한, 개인의 유전자 프로파일에 따라 치료법을 조정하는 개인 맞춤형 의료로의 전환으로 인해 종합적인 헤모글로빈증 검사의 필요성이 높아지고 있습니다. 코로나19 사태로 인해 가속화된 원격의료와 원격진단의 부상은 환자들이 집에서도 쉽게 검사 서비스를 이용할 수 있도록 돕고 있습니다.

헤모글로빈혈증 검사 시장의 성장을 가속하는 요인은 무엇인가?

시장 상황의 성장은 진단 헬스케어의 전망을 재구성하는 몇 가지 요인에 의해 주도되고 있습니다. 차세대 염기서열 분석(NGS), 첨단 유전자 분석 도구의 채택 등 기술 혁신으로 검사법의 정확성과 신뢰성이 향상되고 있습니다. 전 세계적으로 헤모글로빈 이상 질환의 유병률이 증가함에 따라 시장 대상 인구가 확대되고 있으며, 이에 따라 광범위하고 접근하기 쉬운 진단 솔루션에 대한 필요성이 높아지고 있습니다. 유전적 건강에 대한 인식 증가와 적극적인 건강관리 등 소비자 행동 트렌드가 검사 수요를 가속화하고 있습니다. 비침습적 검사법과 현장 검사법의 통합은 환자의 접근성과 편의성을 향상시켜 시장 도입을 더욱 촉진하고 있습니다. 또한, 규제 당국의 지원과 유리한 상환 정책이 첨단 진단 도구의 개발 및 사용을 촉진하고 있습니다. 진단 제약회사와 의료 서비스 제공업체의 협업은 혁신을 촉진하고, 사용 가능한 검사 범위를 확대하여 종합적이고 효과적인 질병 관리를 가능하게 합니다. 이러한 요인의 총체로서, 헤모글로빈혈증 검사 시장의 역동적이고 빠른 진화를 강조하고, 미래의 맞춤형 의료의 중요한 요소로 자리매김하고 있습니다.

부문

검사 유형(HPLC 검사, 질량분석, Hb 전기영동), 최종사용자(참조 실험실, 병원, 학술 및 의료기관)

조사 대상 기업 예

  • BioMedomics Inc.
  • Bio-Rad Laboratories, Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer, Inc.
  • Streck, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

AI 통합

당사는 유효한 전문가 컨텐츠와 AI툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.11.10

Global Adult Hemoglobinopathy Testing Market to Reach US$514.5 Million by 2030

The global market for Adult Hemoglobinopathy Testing estimated at US$399.6 Million in the year 2024, is expected to reach US$514.5 Million by 2030, growing at a CAGR of 4.3% over the analysis period 2024-2030. Reference Laboratories End-Use, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$337.2 Million by the end of the analysis period. Growth in the Hospitals End-Use segment is estimated at 4.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$105.0 Million While China is Forecast to Grow at 6.6% CAGR

The Adult Hemoglobinopathy Testing market in the U.S. is estimated at US$105.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$110.2 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 3.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Adult Hemoglobinopathy Testing Market - Key Trends and Drivers Summarized

What Is Adult Hemoglobinopathy Testing and Why Is It Crucial?

Adult hemoglobinopathy testing is a vital diagnostic process used to detect hemoglobin disorders, such as sickle cell disease and thalassemia, in adults. These genetic conditions can lead to severe health complications, including anemia, pain episodes, and organ damage. Testing typically involves a combination of methods, such as complete blood counts (CBC), hemoglobin electrophoresis, high-performance liquid chromatography (HPLC), and genetic testing to identify abnormal hemoglobin variants and mutations. Early and accurate diagnosis through hemoglobinopathy testing is crucial for effective disease management, enabling healthcare providers to develop personalized treatment plans that can significantly improve patient outcomes and quality of life. As these disorders are often inherited, testing also plays a critical role in genetic counseling and family planning.

How Are Technological Innovations Enhancing Hemoglobinopathy Testing?

Technological advancements are significantly enhancing the capabilities and accuracy of hemoglobinopathy testing. The integration of next-generation sequencing (NGS) and advanced genetic testing methods has revolutionized the field, allowing for more precise identification of genetic mutations associated with hemoglobin disorders. Innovations in bioinformatics and data analytics further enhance the interpretation of complex genetic data, making it possible to detect even rare and subtle variations. Additionally, the development of non-invasive testing techniques, such as liquid biopsy and point-of-care testing, is improving accessibility and convenience for patients. These advancements are not only increasing the diagnostic accuracy but also reducing the time and cost associated with traditional testing methods, making hemoglobinopathy testing more efficient and widely available.

What Trends Are Driving the Adoption of Hemoglobinopathy Testing?

Several key trends are driving the adoption of adult hemoglobinopathy testing across the healthcare sector. The increasing prevalence of hemoglobin disorders worldwide is a significant factor, as early detection and management are essential for mitigating long-term health impacts. Growing awareness and education campaigns about genetic diseases are also encouraging more individuals to seek testing. The expansion of genetic counseling services, which provide valuable insights into hereditary conditions and guide family planning decisions, is further boosting demand for diagnostic tests. Additionally, the shift towards personalized medicine, where treatments are tailored based on individual genetic profiles, is driving the need for comprehensive hemoglobinopathy testing. The rise of telehealth and remote diagnostics, accelerated by the COVID-19 pandemic, is making it easier for patients to access testing services from the comfort of their homes.

What Factors Are Driving Growth in the Hemoglobinopathy Testing Market?

The growth in the adult hemoglobinopathy testing market is driven by several factors reshaping the landscape of diagnostic healthcare. Technological innovations, such as the adoption of next-generation sequencing (NGS) and advanced genetic analysis tools, are enhancing the precision and reliability of testing methods. The increasing incidence of hemoglobin disorders globally is expanding the market's addressable population, necessitating widespread and accessible diagnostic solutions. Consumer behavior trends, including heightened awareness of genetic health and proactive health management, are accelerating the demand for testing. The integration of non-invasive and point-of-care testing methods is improving patient accessibility and convenience, further driving market adoption. Additionally, regulatory support and favorable reimbursement policies are encouraging the development and use of advanced diagnostic tools. Collaborations between diagnostic companies and healthcare providers are fostering innovation and expanding the range of available tests, ensuring comprehensive and effective disease management. These factors collectively underscore the dynamic and rapidly evolving nature of the hemoglobinopathy testing market, positioning it as a critical component in the future of personalized healthcare.

SCOPE OF STUDY:

The report analyzes the Adult Hemoglobinopathy Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Test Type (HPLC Test, Mass Spectrometry, Hb Electrophoresis); End-Use (Reference Laboratories, Hospitals, Academic & Medical Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • BioMedomics Inc.
  • Bio-Rad Laboratories, Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • PerkinElmer, Inc.
  • Streck, Inc.
  • Thermo Fisher Scientific, Inc.
  • Trinity Biotech PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • Adult Hemoglobinopathy Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advancements in Genetic Testing Propel Growth in Adult Hemoglobinopathy Testing
    • Increasing Prevalence of Hemoglobin Disorders Spurs Demand for Diagnostic Solutions
    • Expansion of Genetic Counseling Services Strengthens Business Case for Hemoglobinopathy Testing
    • Rising Awareness and Early Detection Campaigns Generate Demand for Adult Hemoglobinopathy Testing
    • Integration of Next-Generation Sequencing (NGS) in Hemoglobinopathy Testing Enhances Accuracy
    • Rising Demand for Non-Invasive Testing Methods Propels Market Growth
    • Increased Focus on Population Screening Programs Drives Adoption
    • Advances in Bioinformatics and Data Analytics Enhance Hemoglobinopathy Testing Accuracy
    • Development of Multiplexed and High-Throughput Testing Platforms Expands Market Applications
    • Increased Focus on Genetic Research and Hemoglobinopathies Propels Market Forward
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for HPLC Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for HPLC Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for HPLC Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Hb Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Hb Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Hb Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic & Medical Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Academic & Medical Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Academic & Medical Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Adult Hemoglobinopathy Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • INDIA
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Adult Hemoglobinopathy Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Adult Hemoglobinopathy Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030
  • AFRICA
    • Adult Hemoglobinopathy Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Adult Hemoglobinopathy Testing by Test Type - HPLC Test, Mass Spectrometry and Hb Electrophoresis Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Adult Hemoglobinopathy Testing by Test Type - Percentage Breakdown of Value Sales for HPLC Test, Mass Spectrometry and Hb Electrophoresis for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Adult Hemoglobinopathy Testing by End-Use - Reference Laboratories, Hospitals and Academic & Medical Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Adult Hemoglobinopathy Testing by End-Use - Percentage Breakdown of Value Sales for Reference Laboratories, Hospitals and Academic & Medical Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제